PGHL

Procter & Gamble Health Share Price

₹5,082.00 -29.5 (-0.58%)

02 May, 2025 02:03

SIP TrendupStart SIP in PGHL

Start SIP

Performance

  • Low
  • ₹5,046
  • High
  • ₹5,150
  • 52 Week Low
  • ₹4,639
  • 52 Week High
  • ₹5,850
  • Open Price₹5,103
  • Previous Close₹5,112
  • Volume7,156

Investment Returns

  • Over 1 Month -1.25%
  • Over 3 Month -5.58%
  • Over 6 Month -2.87%
  • Over 1 Year + 3.51%
SIP Lightning

Smart Investing Starts Here Start SIP with Procter & Gamble Health for Steady Growth!

Invest Now

Procter & Gamble Health Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.7
  • PEG Ratio
  • 8.1
  • Market Cap Cr
  • 8,436
  • P/B Ratio
  • 13.6
  • Average True Range
  • 133.92
  • EPS
  • 147.87
  • Dividend Yield
  • 2.8
  • MACD Signal
  • -25.17
  • RSI
  • 43.07
  • MFI
  • 42.68

Procter & Gamble Health Financials

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹5,082.00
-29.5 (-0.58%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹5,176.87
  • 50 Day
  • ₹5,223.36
  • 100 Day
  • ₹5,248.79
  • 200 Day
  • ₹5,225.98

Resistance and Support

5092.5 Pivot Speed
  • R3 5,244.00
  • R2 5,197.00
  • R1 5,139.50
  • S1 5,035.00
  • S2 4,988.00
  • S3 4,930.50

What's your outlook on Procter & Gamble Health?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

P&G Health is a leading global healthcare company specializing in consumer health products, including over-the-counter medications and dietary supplements. With a focus on innovation and quality, it aims to enhance the well-being of individuals and families worldwide.

Procter & Gamble Health has an operating revenue of Rs. 1,159.54 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 24% is great, ROE of 37% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 75 which is a FAIR score but needs to improve its earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Procter & Gamble Health Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-29 Audited Results & Final Dividend
2025-02-12 Quarterly Results & Interim Dividend
2024-11-04 Quarterly Results
2024-08-21 Audited Results & Final Dividend
2024-05-02 Quarterly Results
Date Purpose Remarks
2025-02-21 INTERIM Rs.80.00 per share(800%)Interim Dividend
2024-02-14 INTERIM Rs.50.00 per share(500%)Interim Dividend
2024-02-14 SPECIAL Rs.150.00 per share(1500%)Special Dividend
2023-02-13 INTERIM Rs.45.00 per share(450%)Interim Dividend
2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend
View More

Procter & Gamble Health F&O

Procter & Gamble Health Shareholding Pattern

51.82%
10.54%
3.47%
6.86%
0%
21.9%
5.41%

About Procter & Gamble Health

  • NSE Symbol
  • PGHL
  • BSE Symbol
  • 500126
  • Managing Director
  • Mr. Milind Thatte
  • ISIN
  • INE199A01012

Similar Stocks to Procter & Gamble Health

Procter & Gamble Health FAQs

Procter & Gamble Health share price is ₹5,082 As on 02 May, 2025 | 01:49

The Market Cap of Procter & Gamble Health is ₹8435.8 Cr As on 02 May, 2025 | 01:49

The P/E ratio of Procter & Gamble Health is 35.7 As on 02 May, 2025 | 01:49

The PB ratio of Procter & Gamble Health is 13.6 As on 02 May, 2025 | 01:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23